Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00407017 · ClinicalTrials.gov registry record · Phase 4
Therapeutic Variables in Cataract Surgery
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00407017: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00407017 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00407017, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.
Interventions
- DRUG Moxifloxacin
- DRUG Gatifloxacin
- DRUG Pred Forte
- DRUG Nepafenac
- DRUG Ketorolac LS
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00407017 record still lists
NCT00407017 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which Moxifloxacin is the first listed.
NCT00407017 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00407017 about?
NCT00407017 is a clinical study titled "Therapeutic Variables in Cataract Surgery". The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.
What is the current status of trial NCT00407017?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00407017?
The interventions under investigation include: Moxifloxacin (DRUG), Gatifloxacin (DRUG), Pred Forte (DRUG), Nepafenac (DRUG), Ketorolac LS (DRUG).
Who is sponsoring clinical trial NCT00407017?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.